Pages that link to "Q70246541"
Jump to navigation
Jump to search
The following pages link to Effects of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy (Q70246541):
Displaying 13 items.
- Modulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modifications (Q27015807) (← links)
- Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response (Q34120367) (← links)
- Diabetic nephropathy in insulin-dependent patients (Q35589614) (← links)
- Current therapeutic management of diabetic nephropathy (Q40574203) (← links)
- Eicosanoids in the pathogenesis of the functional and structural alterations of the kidney in diabetes (Q40779242) (← links)
- Role for thromboxane A2 from glomerular thrombi in nephropathy with type 2 diabetic rats (Q44392609) (← links)
- Acute and chronic effects of thromboxane A2 inhibition on the renal hemodynamics in streptozotocin-induced diabetic rats (Q51638707) (← links)
- Thromboxane in the pathogenesis of glomerular injury in diabetes (Q67595214) (← links)
- Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients (Q71812061) (← links)
- Renal production of thromboxane and prostaglandins in a rat model of type 2 diabetes (Q73439904) (← links)
- A central role for protein kinase C overactivity in diabetic glomerulosclerosis: implications for prevention with antioxidants, fish oil, and ACE inhibitors (Q74510523) (← links)
- Diverse associations between oxidative stress and thromboxane A2 in hypertensive glomerular injury (Q90439962) (← links)
- Ozagrel a thromboxane A2 synthase inhibitor extenuates endothelial dysfunction, oxidative stress and neuroinflammation in rat model of bilateral common carotid artery occlusion induced vascular dementia (Q104511838) (← links)